SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic.

Saketkoo, LA; Jensen, K; Nikoletou, D; Newton, JJ; Rivera, FJ; Howie, M; Reese, RK; Goodman, M; Hart, PB; Bembry, W; et al. Saketkoo, LA; Jensen, K; Nikoletou, D; Newton, JJ; Rivera, FJ; Howie, M; Reese, RK; Goodman, M; Hart, PB; Bembry, W; Russell, A; Lian, I; Lammi, MR; Scholand, MB; Russell, A-M (2022) Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic. J Patient Exp, 9. p. 23743735221075556. ISSN 2374-3735 https://doi.org/10.1177/23743735221075556
SGUL Authors: Nikoletou, Dimitra

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB) | Preview

Abstract

Background: Inspired by intense challenges encountered by patients and clinicians, we examined the experiences of living with sarcoidosis in three of the hardest impacted English-speaking cities during the early COVID-19 pandemic: London, New Orleans, and New York. Methods: A multi-disciplinary, multi-national research team including 6 patient leaders conducted qualitative investigations with analyses rooted in grounded theory. Recruitment occurred by self-referral through patient advocacy groups. Results: A total of 28 people living with sarcoidosis participated. The majority of patients had multi-system and severe sarcoidosis. Dominant themes were consistent across groups with differences expressed in spirituality and government and health systems. Racial, gender, and able-bodied inequity were voiced regarding healthcare access and intervention, societal interactions, and COVID-19 exposure and contraction. Agreement regarding extreme disruption in care and communication created concern for disability and survival. Concerns of COVID-19 exposure triggering new sarcoidosis cases or exacerbating established sarcoidosis were expressed. Pre-COVID-19 impediments in sarcoidosis healthcare delivery, medical knowledge, and societal burdens were intensified during the pandemic. Conversely, living with sarcoidosis cultivated personal and operational preparedness for navigating the practicalities and uncertainties of the pandemic. Optimism prevailed that knowledge of sarcoidosis, respiratory, and multi-organ diseases could provide pathways for COVID-19-related therapy and support; however, remorse was expressed regarding pandemic circumstances to draw long-awaited attention to multi-organ system and respiratory conditions. Conclusion: Participants expressed concepts warranting infrastructural and scientific attention. This framework reflects pre- and intra-pandemic voiced needs in sarcoidosis and may be an agent of sensitization and strategy for other serious health conditions. A global query into sarcoidosis will be undertaken.

Item Type: Article
Additional Information: © The Author(s) 2022 This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: COVID, chronic, disparities, multi-organ, multi-system, patient-centered, quality of life, sarcoidosis, sarcoidosis, patient-centered, multi-system, multi-organ, quality of life, chronic, disparities, COVID
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Journal or Publication Title: J Patient Exp
ISSN: 2374-3735
Language: eng
Dates:
DateEvent
24 March 2022Published
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
L30 HL129466NHLBI NIH HHSUNSPECIFIED
PubMed ID: 35350664
Web of Science ID: WOS:000775499700001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114702
Publisher's version: https://doi.org/10.1177/23743735221075556

Actions (login required)

Edit Item Edit Item